ArticleReviews in cardiovascular medicine2026
Outcome Stratification in Non-ST-Segment Elevation Myocardial Infarction: Standardized Assessment of Left Ventricular Global Longitudinal Strain.
Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left ventricular global longitudinal strain (LVGLS) is a sensitive index of left ventricular systolic function. However, the prognostic value of this metric in patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) has not been fully established. Methods: We retrospectively enrolled patients with newly diagnosed NSTEMI at Hunan Provincial People's Hospital between April 2020 and October 2023. All participants underwent transthoracic echocardiography (TTE) within 48 hours before coronary revascularization. Major adverse cardiovascular events (MACEs) were defined as readmission for unstable angina, non-fatal myocardial infarction, readmission for heart failure, or cardiac death. Results: We followed 181 patients with NSTEMI for a median of 599 days (interquartile range (IQR): 297-800). MACEs occurred in 40 patients. Patients who experienced MACEs had significantly worse LVGLS than those without events (-11.00 [-13.70, -7.77] vs. -16.10 [-18.90, -13.50]; Conclusions: LVGLS is a strong, independent predictor of adverse cardiovascular events and may improve early risk stratification in patients with NSTEMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.